Aplyronine
A (ApA) is an antitumor marine macrolide that induces
an protein–protein interaction (PPI) between actin and tubulin.
The C1–C9 macrolactone part including the C7
N
,
N
,
O
-trimethylserine (TMSer) ester
is important for its highly potent activities. To develop new antitumor
PPI inducers, four aplyronine analogues were synthesized, which bear
the C1–C9 macrolactone part with 0–2 TMSer ester(s)
and the C24–C34 actin-binding side chain. Despite exhibiting
potent actin-depolymerizing activity comparable to that of ApA, these
analogues did not show potent cytotoxicity or depolymerize microtubules.
Molecular modeling studies suggested that the whole macrolactone moiety
of aplyronines was important to fix the conformation of the C7 TMSer
ester moiety, while the linear C1–C9 part was insufficient.
Still, our study newly proposed that fixed conformations of the C7
or C9 TMSer esters in aplyronines that protrude from the actin surface
are important for binding to tubulin and inhibit microtubule dynamics.